On April 20th, BAHBL hosted an invitation-only evening for dozens of CEOs, CFOs, and other life science C-Suite leaders at Traverse in South San Francisco. The night started off with a happy hour filled with drinks, appetizers, and networking. Following that fun, we had a…
Venture capital (VC) fundraising was unprecedented in H1 2022. Despite a slowdown in H2, funds closed out the year with nearly $22B to invest into healthcare companies, second only to the record $28B raised in 2021... healthcare-investments-and-exits-annual-report-2022
A strong IPO environment, plus an upswing in private M&A, propelled a fourth straight record year in healthcare venture capital (VC) fundraising. 2020 VC fundraising far exceeded 2019’s record with an unprecedented $17B in new venture funds dedicated to healthcare. Healthcare company investment surged more…